Mayo Clinic Arizona to Offer New Treatment for Recurrent Glioblastoma

Mayo Clinic in Scotsdale, Ariz., is the first and only clinical center in the Southwest to offer a new treatment that disrupts the growth of recurrent glioblastoma brain tumors. The new treatment features the NovoTTF-100A System — a portable, noninvasive medical device that affixes to a patient’s head and provides continuous electrical pulses targeted to tumor sites throughout the day. The device has been shown to slow and reverse tumor growth by inhibiting mitosis, the process by which cells divide and replicate.

“Glioblastoma is a difficult disease, and what is exciting is that we’re now able to offer a treatment option to patients who have not been able to tolerate other treatments,” says Alyx Porter-Umphrey, MD, neuro-oncologist at Mayo Clinic in Arizona. For more information, click here to read the full release.